PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran. zalizade@yahoo.com.\', \'Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran. nkeyhanian1366@gmail.com.\', \'Department of Infectious Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran. sghaderkhani@gmail.com.\', \'Department of Pharmacology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran. dashtis@sina.tums.ac.ir.\', \'Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran. rshokouhi@farabi.tums.ac.ir.\', \'Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran. pourpakz@sina.tums.ac.ir.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • Iranian journal of allergy, asthma, and immunology
is ?:pmid of
?:pmid
?:pmid
  • 34418903
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • A Pilot Study on Controlling Coronavirus Disease 2019 (COVID-19) Inflammation Using Melatonin Supplement.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all